Zydus Cadila Gets DGCI Nod for Phase 3 Covid Vaccine Clinical Trials with Biological Therapy


Team Udayavani, Dec 4, 2020, 1:39 PM IST

Drug firm Zydus Cadila on Friday said it has received the approval fromthe Drugs Controller General of India (DCGI) to start phase 3 clinical trials with its biological therapy PegiHep in COVID-19 patients. The company had completed the phase 2 clinical trials with PegiHep last month.

In a regulatory filing, Zydus Cadila said it has received approval from the DCGI to start the phase 3 clinical trials in COVID-19 patients with its biological therapy Pegylated Interferon alpha-2b or PegiHep. The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India, according to the filing.

Sharvil Patel, Managing Director of Cadila Healthcare Ltd, said, “we are encouraged by the results of phase 2 study of Pegylated Interferon alpha 2-b which has shown the potential to reduce virus titres when given earlier in the disease. “Our efforts are to look at possible treatment options to fight COVID-19 which are safe, can be administered easily and also reduce the disease burden”.

Further, the company said it is conducting a similar phase 2 trial in Mexico and is also working withthe US Food and Drug Administration (USFDA) toopen an Investigational New Drug (IND) application for PegiHep in order to initiate appropriate clinical trials in the US.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Youth attempts suicide after being humiliated in public for wearing ripped jeans in Belthangady

India crawl to 51 for 4 after losing top-order

Nursing student suicide: Three students arrested in Kerala

Nadda’s letter to Kharge full of falsehoods: Cong

10 month baby gets new heart, new life

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial

Related Articles More

Baku climate talks: The ‘X’ factor that could determine future of Global South

India-US ties have strong foundation: White House confident in navigating crisis over Adani bribery charges

PM Modi leaves for home after concluding three-nation visit

China announces new policy measures to protect its exports from Trump’s new tariff threat

Pak government prepares for proposed protest by former PM Imran Khan’s party on Nov 24

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

Youth attempts suicide after being humiliated in public for wearing ripped jeans in Belthangady

Baku climate talks: The ‘X’ factor that could determine future of Global South

Kerala HC denies bail to police officer accused of ‘raping’ minor Dalit girl

Global Bhagavad Gita Quiz Announced: Registration now open

Kasaragod: Husband murders woman PSI

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.